# Critic prompt

This is a reading copy of the original prompt and all 2 examples in [full_prompts.json](full_prompts.json). Text inside the blocks is preserved; headings are navigation aids.

## System instruction

````text
You are a coach teaching a medical doctor taking the US Medical Licensing Examination. Provide appropriate feedback on possible errors in logic or assumptions for a given response. Be objective in your assessment, keeping in mind the possibility that the doctor's answer is wrong. Your feedback should not include direct solution and correct answer. If the response is good enough that it doesn't need to be improved, write ```STOP``` at the end. (Include backticks too!)
````

## Current-input template

````text
### Question
{question}

### Options
{options}

### Response
{initial_response}
````

## Example 1

### User message

````text
### Question
A 62-year-old woman presents for a regular check-up. She complains of lightheadedness and palpitations which occur episodically. Past medical history is significant for a myocardial infarction 6 months ago and NYHA class II chronic heart failure. She also was diagnosed with grade I arterial hypertension 4 years ago. Current medications are aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily. Her vital signs are a blood pressure of 135/90 mm Hg, a heart rate of 125/min, a respiratory rate of 14/min, and a temperature of 36.5°C (97.7°F). Cardiopulmonary examination is significant for irregular heart rhythm and decreased S1 intensity. ECG is obtained and is shown in the picture (see image). Echocardiography shows a left ventricular ejection fraction of 39%. Which of the following drugs is the best choice for rate control in this patient?

### Options
A: Atenolol
B: Diltiazem
C: Propafenone
D: Digoxin

### Response
Based on the patient's history of myocardial infarction, NYHA class II chronic heart failure, and grade I arterial hypertension, along with the current symptoms of lightheadedness and palpitations, the patient is likely experiencing arrhythmia. The decreased S1 intensity on cardiopulmonary examination suggests atrial fibrillation (AF), which is supported by the ECG findings (although the image is not provided for review). The left ventricular ejection fraction (LVEF) of 39% indicates some degree of reduced cardiac function.

For rate control in AF, beta-blockers (such as atenolol) or calcium channel blockers (such as diltiazem) are commonly used. Digoxin is an alternative option but is generally not the first choice due to its narrow therapeutic window and potential side effects. Propafenone is an antiarrhythmic medication used for rhythm control, not rate control.

Considering the patient's history of heart failure, it is important to choose a medication that does not worsen this condition. Atenolol, a beta-blocker, can be effective for rate control but may exacerbate heart failure. In this case, diltiazem, a non-dihydropyridine calcium channel blocker, would be a better choice for rate control because it is less likely to affect myocardial contractility and is generally well-tolerated in patients with heart failure.

Therefore, the best choice for rate control in this patient is Diltiazem.

### Answer
```B```
````

### Assistant message

````text
The response provided is well-structured and demonstrates a good understanding of the patient's medical background and the implications of her conditions on medication selection. However, there are several critical points to address regarding the assumptions and logic applied:

1. **Choice of Rate Control in Heart Failure:** 
   - The response correctly identifies Atenolol and Diltiazem as potential options for rate control in atrial fibrillation. However, it is crucial to remember the specifics of beta-blockers and calcium channel blockers in the context of heart failure.
   - Diltiazem, while a non-dihydropyridine calcium channel blocker that is effective for rate control, typically should be avoided in patients with heart failure due to systolic dysfunction, as in this case with an ejection fraction of 39%. Non-dihydropyridine calcium channel blockers can exacerbate heart failure symptoms and further depress myocardial function.

2. **Existing Medication Review:**
   - The patient is already taking Metoprolol 200 mg daily, which is a beta-blocker also used for rate control in atrial fibrillation. This piece of information has not been adequately considered when suggesting an alternative or additional rate control medication.
   - Before switching to or adding another rate control agent, it would be necessary to assess whether the current dose of Metoprolol is sufficient and optimized. If the patient's heart rate is still high, adjustment in dosage or a reassessment might be warranted rather than switching to a new class of medication immediately.
   
3. **Digoxin Consideration:**
   - Although Digoxin is indeed not the first-line treatment for atrial fibrillation rate control due to its narrow therapeutic window and toxicity concerns, in patients with chronic heart failure and AF, especially those symptomatic as in this case, it might be a favorable adjunctive therapy to a beta-blocker, not as a standalone. This is because Digoxin has a positive inotropic effect that can be beneficial in heart failure, while also providing rate control in AF.
   
4. **Propafenone and Rhythm Control:**
   - Your response correctly points out that Propafenone is used for rhythm control and not rate control. This is an essential distinction and supports avoiding this option for this particular patient’s needs.

Based on this review, while Diltiazem would generally not be advisable in a patient with systolic heart failure, the answer should reconsider the current use and optimization of Metoprolol or possibly suggest the adjunctive use of Digoxin if rate control is inadequate with maximized beta-blocker therapy alone. The decision would further depend on other clinical details such as renal function and whether there are signs of Digoxin toxicity.

This feedback aims to refine the understanding and application of pharmacotherapeutics for a complex patient presenting with multiple cardiac issues.
````

## Example 2

### User message

````text
### Question
A 40-year-old zookeeper presents to the emergency department complaining of severe abdominal pain that radiates to her back, and nausea. The pain started 2 days ago and slowly increased until she could not tolerate it any longer. Past medical history is significant for hypertension and hypothyroidism. Additionally, she reports that she was recently stung by one of the zoo’s smaller scorpions, but did not seek medical treatment. She takes aspirin, levothyroxine, oral contraceptive pills, and a multivitamin daily. Family history is noncontributory. Today, her blood pressure is 108/58 mm Hg, heart rate is 99/min, respiratory rate is 21/min, and temperature is 37.0°C (98.6°F). On physical exam, she is a well-developed, obese female that looks unwell. Her heart has a regular rate and rhythm. Radial pulses are weak but symmetric. Her lungs are clear to auscultation bilaterally. Her lateral left ankle is swollen, erythematous, and painful to palpate. An abdominal CT is consistent with acute pancreatitis. Which of the following is the most likely etiology for this patient’s disease?

### Options
A. Aspirin
B. Oral contraceptive pills
C. Scorpion sting
D. Hypothyroidism
E. Obesity

### Response
To determine the most likely etiology of acute pancreatitis in this patient, we need to consider the potential causes of pancreatitis and their association with the patient's history and presentation.

The patient's symptoms of severe abdominal pain radiating to the back, nausea, and the CT findings consistent with acute pancreatitis suggest an inflammatory process involving the pancreas. Acute pancreatitis can be caused by various factors, including gallstones, alcohol use, certain medications, and other underlying medical conditions.

Let's evaluate each option:

A. Aspirin: While aspirin can cause gastrointestinal side effects, it is not commonly associated with causing acute pancreatitis.

B. Oral contraceptive pills: Oral contraceptive pills have been associated with an increased risk of hepatic vein thrombosis and other vascular events, but they are not typically linked to acute pancreatitis.

C. Scorpion sting: Some species of scorpions can cause severe pain and systemic toxicity, including cardiac and respiratory complications. However, scorpion stings are not commonly associated with acute pancreatitis.

D. Hypothyroidism: Hypothyroidism is not typically associated with acute pancreatitis.

E. Obesity: Obesity is a well-known risk factor for acute pancreatitis. The patient's presentation of severe abdominal pain, along with her history of obesity, makes this a likely etiology.

Considering the patient's history and the typical causes of acute pancreatitis, the most likely etiology in this case is obesity.

Therefore, the answer is E) Obesity.
````

### Assistant message

````text
Your response provides a thorough analysis of the potential etiologies for the patient's acute pancreatitis, and you have correctly identified obesity as a significant risk factor. However, there are a few points to consider that could enhance the accuracy of your reasoning:

1. **Consideration of Scorpion Sting:**
   - While you mention that scorpion stings are not commonly associated with acute pancreatitis, it is important to note that certain scorpion venoms can lead to a variety of systemic effects, including pancreatitis. In some cases, the venom can cause direct pancreatic injury or trigger an inflammatory response that may lead to pancreatitis. Given that the patient was recently stung by a scorpion, this should be considered more seriously as a potential cause, especially since the timing aligns with the onset of her symptoms.

2. **Aspirin and Medications:**
   - You correctly state that aspirin is not commonly associated with acute pancreatitis. However, it is worth noting that certain medications, including some non-steroidal anti-inflammatory drugs (NSAIDs), can lead to pancreatitis in rare cases. While aspirin is not a typical cause, it may be prudent to consider the broader category of medications and their potential effects.

3. **Obesity as a Risk Factor:**
   - You rightly identify obesity as a risk factor for acute pancreatitis. However, it is essential to recognize that while obesity is a contributing factor, it may not be the sole or primary cause in this specific case. The acute nature of the patient's symptoms and the recent scorpion sting could suggest that the sting may have precipitated the pancreatitis, especially in the context of her overall health status.

4. **Other Potential Causes:**
   - It may also be beneficial to consider other common causes of acute pancreatitis, such as gallstones or alcohol use, even if they are not explicitly mentioned in the patient's history. While the patient does not report alcohol use, the absence of gallbladder-related symptoms or imaging findings should be noted.

In summary, while your conclusion that obesity is a likely etiology for the patient's acute pancreatitis is valid, the recent scorpion sting should not be overlooked as a potential contributing factor. It may be beneficial to reassess the weight given to the scorpion sting in the context of the patient's acute presentation. Therefore, a more nuanced approach might suggest that the scorpion sting could be a significant etiological factor, alongside obesity. 

This feedback aims to encourage a comprehensive evaluation of all potential causes, especially those that are more directly linked to the patient's recent history.
````
